Bernard Coulie Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 8 months, 2 weeks ago
Bernard Coulie has an estimated net worth of at least $14.3 million*, as of June 18, 2025. They own shares of PLRX stock. They have sold 633,926 shares of PLRX stock since 2021, for an estimated $13.0 million.
Bernard Coulie $PLRX SEC Form 4 Insider Trading
Bernard Coulie has filed a total of 40 insider trades in $PLRX since 2021. Their most recent trade was a sale of 89,375 shares, made on Jan 20, 2026. Their largest trade was a sale of 89,375 shares, made on Jan 20, 2026. We estimate that they now own shares of $PLRX, worth an estimated $1.4 million.
Insider Trading at $PLRX
There have been a total of 84 insider trades reported at $PLRX since 2021, with 0 shares purchased and 1.2 million shares sold. The most active insider traders in $PLRX stock have been Bernard Coulie, Eric Lefebvre, and Mike Ouimette. The most recent trade was a sale of 24,002 shares reported by Keith Lamont Cummings (Chief Financial Officer), made on Jan 20, 2026.
History of Insider Stock Trades by Bernard Coulie
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
PLRX
|
Sale | 89,375 | Jan 20, 2026 | Jan. 22, 2026, 10:38 p.m. |
PLRX
|
Sale | 52,419 | Jan 17, 2025 | Jan. 22, 2025, 7:07 p.m. |
PLRX
|
Sale | 38,710 | Jul 10, 2024 | July 12, 2024, 6:22 p.m. |
PLRX
|
Sale | 25,721 | Jan 17, 2024 | Jan. 19, 2024, 6:19 p.m. |
PLRX
|
Sale | 70,150 | Jul 17, 2023 | July 19, 2023, 8:20 p.m. |
PLRX
|
Sale | 35,339 | Mar 30, 2023 | April 3, 2023, 6:46 p.m. |
PLRX
|
Sale | 5,262 | Feb 03, 2023 | Feb. 6, 2023, 6:45 p.m. |
PLRX
|
Sale | 13,395 | Feb 02, 2023 | Feb. 6, 2023, 6:45 p.m. |
PLRX
|
Sale | 1,605 | Feb 02, 2023 | Feb. 6, 2023, 6:45 p.m. |
PLRX
|
Sale | 9,738 | Feb 03, 2023 | Feb. 6, 2023, 6:45 p.m. |
PLRX
|
Sale | 5,440 | Feb 01, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 105 | Feb 01, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 11,395 | Jan 30, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 3,605 | Jan 30, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 15,000 | Jan 31, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 9,455 | Feb 01, 2023 | Feb. 1, 2023, 10:43 p.m. |
PLRX
|
Sale | 8,698 | Jan 27, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 6,302 | Jan 27, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 9,779 | Jan 27, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 221 | Jan 27, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 15,000 | Jan 26, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 15,000 | Jan 26, 2023 | Jan. 27, 2023, 8:15 p.m. |
PLRX
|
Sale | 4,850 | Jan 23, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 15,000 | Jan 24, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 13,304 | Jan 25, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 1,696 | Jan 25, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 10,150 | Jan 23, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 15,000 | Jan 23, 2023 | Jan. 25, 2023, 10 p.m. |
PLRX
|
Sale | 15,000 | Jan 06, 2023 | Jan. 9, 2023, 9:16 p.m. |
PLRX
|
Sale | 5,000 | Jan 09, 2023 | Jan. 9, 2023, 9:16 p.m. |
PLRX
|
Sale | 15,000 | Jan 03, 2023 | Jan. 5, 2023, 8:44 p.m. |
PLRX
|
Sale | 15,000 | Jan 04, 2023 | Jan. 5, 2023, 8:44 p.m. |
PLRX
|
Sale | 34,212 | Dec 20, 2022 | Dec. 21, 2022, 10:32 p.m. |
PLRX
|
Sale | 12,502 | Sep 12, 2022 | Sept. 14, 2022, 5:31 p.m. |
PLRX
|
Sale | 15,000 | Jul 11, 2022 | July 13, 2022, 7:05 p.m. |
PLRX
|
Sale | 12,498 | Jul 12, 2022 | July 13, 2022, 7:05 p.m. |
PLRX
|
Sale | 3,757 | Jun 14, 2021 | June 14, 2021, 8 p.m. |
PLRX
|
Sale | 3,757 | Jun 14, 2021 | June 14, 2021, 8 p.m. |
PLRX
|
Sale | 243 | Jun 14, 2021 | June 14, 2021, 8 p.m. |
PLRX
|
Sale | 243 | Jun 14, 2021 | June 14, 2021, 8 p.m. |
$PLRX Executives and Stock Owners with Insider Trades
-
Bernard Coulie, President and CEO
-
Eric Lefebvre, Chief Medical Officer
-
Mike Ouimette, General Counsel & Corp. Sec'y
-
Hans Hull, Chief Business Officer
-
Keith Lamont Cummings, Chief Financial Officer
-
Lily Cheung, Chief Human Resource Officer
-
Minnie Kuo, Chief Operating Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.